Investment analysts at StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a research note issued on Sunday. The brokerage set a “hold” rating on the stock.
China Pharma Price Performance
Shares of NYSE:CPHI opened at $0.25 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.25 and a current ratio of 0.89. China Pharma has a 1-year low of $0.24 and a 1-year high of $2.05. The company has a 50 day moving average price of $0.30 and a 200 day moving average price of $0.40.
China Pharma (NYSE:CPHI – Get Free Report) last announced its quarterly earnings data on Wednesday, May 15th. The company reported ($0.07) EPS for the quarter. The company had revenue of $1.37 million for the quarter. China Pharma had a negative net margin of 55.42% and a negative return on equity of 54.31%.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
See Also
- Five stocks we like better than China Pharma
- What is Insider Trading? What You Can Learn from Insider Trading
- McDonald’s Stock: Balancing Value and Innovation
- How to Calculate Stock Profit
- MarketBeat Week in Review – 6/17 – 6/21
- Why Are Stock Sectors Important to Successful Investing?
- Sarepta Therapeutics Stock Soars on FDA Approval
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
